Adult Dosing
- Adult dosing is not applicable
Pediatric Dosing
Active immunization against Haemophilus influenzae type b
Age at first dose: 2-10 months
- 0.5 mL IM x 2 doses 2 months apart, followed by 0.5 mL boster dose at 12-15 months of age
Age at first dose: 11-14 months
- 0.5 mL IM x 2 doses 2 months apart
Age at first dose: 15-71 months
[Outline]
See Supplemental Patient Information
- For intramuscular use only. Ensure that vaccine is not injected into a blood vessel
- Patients with minor illnesses such as diarrhea, mild upper-respiratory infection with or without low-grade fever may receive the vaccine; however, those with moderate or severe febrile illness should be vaccinated only after recovery from acute phase of the illness
- Keep adequate treatment provisions, including epinephrine readily available in the event of an anaphylactoid reaction
- Vial stopper contains dry natural latex rubber that may result in allergic reactions. Use cautiously in latex-sensitive individuals
- Cases of Hib disease have been reported in the week following vaccination, prior to the onset of the protective effects of the vaccines
- There is inadequate evidence to support post-exposure disease prevention when given immediately after exposure to natural Haemophilus influenzae type b
- Urine antigen detection may not give a diagnostic in suspected disease due to H. influenzae type b within 1 to 2 weeks vaccination
- Patients with malignancies, those receiving immunosuppressants, or who are otherwise immunocompromised may not receive the expected immune response with the vaccine
Cautions: Use cautiously in
- Latex-sensitive patients
- Immunocompromised patients
- Acute illness
Supplemental Patient Information
- Inform the patient, parent or guardian about the benefits and risks associated with vaccination
Pregnancy Category:C
Breastfeeding: As per the CDC and several health professional organizations, vaccines given to a nursing mother do not affect the safety of breastfeeding for mothers or infants. Nursing is not a contraindication to vaccination with haemophilus vaccines. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 23 December 2013). Safety unknown as per manufacturer.
